Diseases that lead to chronic production of IL-1β and TNF-a, such as autoinflammatory syndromes and rheumatoid arthritis, can be a target for Resv, especially considering that the incidence of these conditions increases with age. This evidence concerns the gene IL1B and rheumatoid arthritis.